Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting

J Thromb Haemost. 2010 Oct;8(10):2313-5. doi: 10.1111/j.1538-7836.2010.03991.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / therapeutic use*
  • Cohort Studies
  • Humans
  • Pulmonary Embolism / therapy
  • Recurrence
  • Research Design
  • Risk
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Venous Thromboembolism / diagnosis*
  • Venous Thromboembolism / epidemiology
  • Venous Thrombosis / therapy

Substances

  • Anticoagulants